Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth

Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress

(2016) Aili Cao et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Clinical Study of Ursodeoxycholic Acid in Barrett's Esophagus Patients

(2016) B. Banerjee et al.   Cancer Prevention Research

The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk

(2016) Wen-Kuan Huang et al.   MEDICINE

Spherical Cancer Models in Tumor Biology

(2015) Louis-Bastien Weiswald et al.   NEOPLASIA

Ursodiol and Colorectal Cancer or Dysplasia Risk in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Meta-Analysis

(2013) Jonathan D. Hansen et al.   DIGESTIVE DISEASES AND SCIENCES

Effect of Ursodeoxycholic Acid Use on the Risk of Colorectal Neoplasia in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

(2013) Siddharth Singh et al.   INFLAMMATORY BOWEL DISEASES

The chemopreventive agent ursodeoxycholic acid inhibits proliferation of colon carcinoma cells by suppressing c-Myc expression

(2012) Roser Peiró-Jordán et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines

(2011) Lu Cao et al.   BMC GASTROENTEROLOGY

UDCA slows down intestinal cell proliferation by inducing high and sustained ERK phosphorylation

(2011) S. Krishna-Subramanian et al.   INTERNATIONAL JOURNAL OF CANCER

The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells

(2010) Elena Dozio et al.   EUROPEAN JOURNAL OF PHARMACOLOGY